First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trial (original) (raw)
Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial
Fariborz Mansour-ghanaei
EXCLI Journal, 2019
View PDFchevron_right
Quadruple of Bismuth, Pantoprazole, Amoxicillin and Metronidazole for the First-Line Helicobacter Pylori Eradication Therapy
kadir yalçın
Lokman Hekim Health Sciences, 2021
View PDFchevron_right
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study
Brendan Crotty
Gastroenterology, 2002
View PDFchevron_right
A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates
Mohammed Fazel
Journal of Gastroenterology and Hepatology, 2001
View PDFchevron_right
Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance
Oykü Tayfur, Serkan Torun
Acta gastro-enterologica Belgica, 2013
View PDFchevron_right
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial
Mahmud Baghbanian
PLOS ONE
View PDFchevron_right
A Randomized Clinical Trial Comparing the Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulce v1 (protocols.io.mdjc24n)
Mahmud Baghbanian
2017
View PDFchevron_right
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari
Helicobacter, 2010
View PDFchevron_right
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
Keng-liang Wu, Chien-chun Kuo
BioMed Research International, 2015
View PDFchevron_right
Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Vanda Plečko
Helicobacter, 2009
View PDFchevron_right
Eradication of Helicobacter pylori Using One-week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
Robin Spiller
Helicobacter, 1996
View PDFchevron_right
Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, Nort...
Bich Nguyen
American Journal of Gastroenterology, 2003
View PDFchevron_right
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Servet Güreşçi
Clinical Gastroenterology and Hepatology, 2013
View PDFchevron_right
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy
Virginia Festa
Alimentary Pharmacology and Therapeutics, 2001
View PDFchevron_right
Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area
Dionyssios Sgouras
Helicobacter, 2013
View PDFchevron_right
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori
Yoriaki Komeda
Oncology, 2017
View PDFchevron_right
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies
JD J D de Korwin
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial
Cathy Emmas
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates
Xavier Calvet
Alimentary Pharmacology & Therapeutics, 2012
View PDFchevron_right
Effectiveness of two quadruple, tetracycline‐or clarithromycin‐containing, second‐line, Helicobacter pylori eradication therapies
Konstantinos Triantafyllou
View PDFchevron_right
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
Robin Spiller
Gastroenterology, 1999
View PDFchevron_right
First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
Cesare Efrati, Lorenzo Ridola, Domenico Alvaro
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2014
View PDFchevron_right
Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection
Mohamad Eloubeidi
United European gastroenterology journal, 2014
View PDFchevron_right
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
Xavier Calvet
Alimentary Pharmacology & Therapeutics, 2011
View PDFchevron_right
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily
Shiu Kum Lam
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin
S. D Georgopoulos
Digestive diseases and sciences, 2000
View PDFchevron_right